Republicans in the U.S. House of Representatives unveiled a 2012 appropriations bill that would cut 11.5 percent from the FDA’s budget.
The proposal comes after several GOP attacks on the FDA, including a February inquiry by Rep. Joe Pitts (R.-Pa.) into why the FDA’s medical device approval process takes longer than the European regulatory process.
Last week medical device advocate Rep. Erik Paulsen (R-Minn.) announced intentions to revamp FDA policies that he says reduce medical technology jobs across the country.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The cut amounts to about $285 million dollars, reports The Hill’s Healthwatch blog.
If successful, the gestures could undermine the federal watchdog agency’s call for stricter 510(k) regulations and even put a wrinkle in the re-authorization of the Medical Device User Fee Act set for 2012.
House hearings on the FDA and medical devices were supposed to take place in April, but were postponed indefinitely.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
